Possible Link Between the World’s Most Widely Used Vaccine and Rare Blood Clots – U.K. Reports Seven Deaths – Canada Restricts Vaccine

Health authorities maintain that the benefits continue to outweigh any risk but recommended health professionals and recipients of the vaccine be cautious about symptoms. (Image: torstensimon / Pixabay)

European Union medical regulator stopped just short of recommending a ban on the Oxford-AstraZeneca vaccine.

The European medicines watchdog reported a “possible link” between AstraZeneca’s Covid-19 vaccine and rare blood clots.

Late Friday, Britain’s Medicines and Healthcare Products Regulatory Agency, or MHRA, reported 30 blood clot cases linked to the AstraZeneca COVID-19 vaccine. The agency confirmed to the BBC that seven people have died from unusual blood clots after getting the vaccine.

The MHRA, World Health Organization and the European Medicines Agency maintain that the benefits continue to outweigh any risk but recommended health professionals and recipients of the vaccine be cautious about symptoms

Other countries, including Germany, France, the Netherlands and Canada, restrict the vaccine’s use to older people.

AstraZeneca is the world’s most widely used vaccine, with more than 100 countries relying on it, particularly in the global south.